Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

299 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The significance of Elf-1 expression in epithelial ovarian carcinoma.
Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Takai N, et al. Int J Mol Med. 2003 Sep;12(3):349-54. Int J Mol Med. 2003. PMID: 12883651
CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
Takai N, Ueda T, Nishida M, Nasu K, Matsuda K, Kusumoto M, Narahara H. Takai N, et al. Oncology. 2006;70(2):97-105. doi: 10.1159/000092585. Epub 2006 Apr 4. Oncology. 2006. PMID: 16601366 Retracted.
A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N, Ueda T, Nishida M, Nasu K, Narahara H. Takai N, et al. Int J Mol Med. 2006 Feb;17(2):323-9. Int J Mol Med. 2006. PMID: 16391833
M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N, Ueda T, Nishida M, Nasu K, Narahara H. Takai N, et al. Gynecol Oncol. 2006 Apr;101(1):108-13. doi: 10.1016/j.ygyno.2005.09.044. Epub 2005 Nov 2. Gynecol Oncol. 2006. PMID: 16263156 Retracted.
Magnetic resonance imaging findings in leiomyoma of the ovary: a case report.
Kawano Y, Takai N, Shimano M, Nasu K, Miyakawa I. Kawano Y, et al. Among authors: takai n. Arch Gynecol Obstet. 2006 Feb;273(5):298-300. doi: 10.1007/s00404-005-0085-z. Epub 2005 Oct 19. Arch Gynecol Obstet. 2006. PMID: 16235051
C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.
Takai N, Ueda T, Kawano Y, Nishida M, Nasu K, Narahara H. Takai N, et al. Oncol Rep. 2005 Nov;14(5):1287-91. Oncol Rep. 2005. PMID: 16211298
The purpose of the present study was to investigate the effects of an exogenously administered cell-permeable synthetic ceramide analogue, C(2)-ceramide (N-acetyl-sphingosine) on the growth, cell cycle, and death of Ishikawa human endometrial carcinoma cells. ...
The purpose of the present study was to investigate the effects of an exogenously administered cell-permeable synthetic ceramide analogue, C …
Expression of c-Ets1 protein in normal human placenta.
Takai N, Ueda T, Narahara H, Miyakawa I. Takai N, et al. Gynecol Obstet Invest. 2006;61(1):15-20. doi: 10.1159/000087855. Epub 2005 Aug 25. Gynecol Obstet Invest. 2006. PMID: 16127276
Adenoid cystic carcinoma of the uterine cervix.
Nishida M, Nasu K, Takai N, Miyakawa I, Kashima K. Nishida M, et al. Among authors: takai n. Int J Clin Oncol. 2005 Jun;10(3):198-200. doi: 10.1007/s10147-004-0466-5. Int J Clin Oncol. 2005. PMID: 15990970
K252a inhibits proliferation of ovarian cancer cells by upregulating p21WAF1.
Takai N, Ueda T, Nishida M, Nasu K, Fukuda J, Miyakawa I. Takai N, et al. Oncol Rep. 2005 Jul;14(1):141-3. Oncol Rep. 2005. PMID: 15944781
Polo-like kinases (Plks) and cancer.
Takai N, Hamanaka R, Yoshimatsu J, Miyakawa I. Takai N, et al. Oncogene. 2005 Jan 10;24(2):287-91. doi: 10.1038/sj.onc.1208272. Oncogene. 2005. PMID: 15640844 Review.
299 results
Jump to page
Feedback